Health

UK Joins to Test Moderna’s mRNA Norovirus Vaccine

A first-of-its-kind clinical trial to test an mRNA vaccine for norovirus, a highly contagious virus known as the “winter vomiting bug,” is launching in the UK and other countries worldwide.

The late-stage trial aims to evaluate the effectiveness of the vaccine in preventing moderate to severe illness and will recruit around 25,000 participants globally.

The vaccine candidate, developed by Moderna, is being tested in multiple countries, including the UK, US, Canada, Japan, Australia, and several South American nations.

According to the UK’s National Institute for Health and Care Research (NIHR), most participants will be aged 60 or older, with approximately 5,000 individuals between 18 and 59. The UK segment of the study will enroll about 2,500 participants from late October 2024 to early 2025.

Norovirus, which causes vomiting and diarrhea, is typically contracted through viral or bacterial infections. While the illness usually resolves within a few days, it can severely impact vulnerable populations such as young children, older adults, and those with weakened immune systems.

Currently, there is no vaccine or specific treatment available, making prevention through vaccination a significant step forward.

Dr. Patrick Moore, co-director of clinical trial network Wessex Research Hubs and lead for the UK study, emphasized the importance of the trial in advancing healthcare.

“Outbreaks of norovirus have huge consequences, both on our health systems and our economy,” he said. “This innovative trial is crucial in helping us advance healthcare and work towards preventing outbreaks.”

The global burden of norovirus is substantial, with approximately 685 million cases and 200,000 deaths annually, particularly in low-income countries.

The economic impact is also severe, costing an estimated $60 billion (€53.8 billion) each year due to healthcare expenses and productivity losses.

In the UK alone, norovirus-related costs are estimated to exceed £100 million (€120 million) annually for the National Health Service (NHS).

The new phase three trial, typically the final step before seeking regulatory approval for a new vaccine or drug, is expected to last about two years.

This stage will assess the vaccine’s ability to protect against moderate to severe cases of norovirus, potentially paving the way for regulatory agencies to approve it for public use if the results are positive.

Moderna, known for its development of one of the mRNA-based COVID-19 vaccines, is leading the charge with this novel norovirus vaccine.

The company’s chief development officer, Melanie Ivarsson, stated, “We are one step closer to potentially providing a new tool to prevent infection from this highly contagious virus.”

The UK’s involvement in the trial is part of a broader 10-year partnership with Moderna, focusing on advancing mRNA research and strengthening the nation’s vaccine manufacturing capabilities.

UK Health Secretary Wes Streeting commented on the initiative’s potential to ease the burden on the healthcare system, noting, “A successful vaccine will help shift our health system away from sickness and towards prevention.”

As the trial begins, hopes are high that this new vaccine could be a game-changer in the fight against norovirus, potentially reducing the number of cases and alleviating pressure on healthcare systems worldwide.

 

ccenews

Recent Posts

GTA 6 Fever Sees Fans Booking Holidays, Buying Consoles and Seeking Early Access

GTA 6 excitement is reaching extraordinary levels as fans prepare for Rockstar's blockbuster release. UK… Read More

8 hours ago

Irish Boxer Lee Reeves Dies Aged 31 Three Months After Dublin Fight

Professional boxer Lee Reeves has died three months after suffering life-threatening injuries during a bout… Read More

8 hours ago

Robert Pattinson Set for James Bond Role After Remarkable Hollywood Career

Robert Pattinson could take another significant step in his Hollywood career by becoming the next… Read More

9 hours ago

Hundreds of Thousands Protest Czech Government Plans for Public Media

Prague witnessed one of the largest demonstrations against the Czech government as hundreds of thousands… Read More

1 day ago

Six Killed in Krakow Shooting as Polish Police Investigate Suspect’s Motive

Poland is investigating a deadly shooting in Krakow that killed six people and injured several… Read More

1 day ago

Ukrainian Drone Strike Hits Russian Warship in Gulf of Finland

Russian naval vessel was reportedly hit by Ukrainian drones near the Gulf of Finland during… Read More

2 days ago

This website uses cookies.